Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Differences in the hepatitis C virus genotypes in different countries

N Takada1, S Takase, A Takada

  • 1Department of Internal Medicine, Kanazawa Medical University, Ishikawa, Japan.

Journal of Hepatology
|March 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human thrombin and calcium bound factor Xa significantly shorten tPA-induced fibrin clot lysis time via neutralization of plasminogen activator inhibitor type 1 activity.

Thrombosis and haemostasis·1998
Same author

Effects of electric footshock and water immersion restraint stresses on fibrinolytic parameters in the plasma of rats.

Thrombosis research·1998
Same author

Proteolysis of highly polysialylated NCAM by the tissue plasminogen activator-plasmin system in rats.

Neuroscience letters·1998
Same author

Remnant-like particle cholesterol is a major risk factor for myocardial infarction in vasospastic angina with nearly normal coronary artery.

Atherosclerosis·1998
Same author

Severe heat stroke associated with high plasma levels of plasminogen activator inhibitor 1.

Burns : journal of the International Society for Burn Injuries·1998
Same author

Solitary fibrous tumor of the pleura causing recurrent hypoglycemia by secretion of insulin-like growth factor II.

Pathology international·1998
Same journal

Durvalumab with gemcitabine-based chemotherapy regimens in advanced biliary tract cancer: primary results from the phase IIIb TOURMALINE study.

Journal of hepatology·2026
Same journal

Reply to "Role of HBV genotype, monitoring, and events after cessation of nucleos(t)ide analogue therapy".

Journal of hepatology·2026
Same journal

When Biology Pushes Back: Lessons From HBsAg-Targeting Therapies in Hepatitis Delta.

Journal of hepatology·2026
Same journal

Moving Too Fast? A Meta-Analysis Calls for Caution on TNF Inhibitors as First-Line Therapy for Autoimmune Hepatitis.

Journal of hepatology·2026
Same journal

Anserine restores antibacterial immunity in cirrhosis via a protective CCL5-mediated hepatocyte-CD44<sup>+</sup>pDC crosstalk.

Journal of hepatology·2026
Same journal

Anti-CCL2-conjugated platelets attenuate early allograft and ischemia-reperfusion injury by inhibiting monocyte infiltration.

Journal of hepatology·2026
See all related articles

Hepatitis C virus (HCV) genotype distribution varies globally, with HCV-K1 prevalent in Japan and China, while HCV-PT is common in the USA and Europe. This study compared HCV genotypes across multiple countries to understand these geographic differences.

Area of Science:

  • Virology
  • Hepatology
  • Epidemiology

Background:

  • Hepatitis C virus (HCV) has been classified into four main types: HCV-PT, -K1, -K2a, and -K2b, based on nucleotide sequence variations.
  • The prototype HCV-PT, initially reported in the USA, shows low prevalence in Japan, indicating potential geographical variations in HCV genotype distribution.

Purpose of the Study:

  • To investigate and compare the prevalence of different hepatitis C virus genotypes across various countries.
  • To determine if HCV genotype distribution differs geographically and between patient groups (non-cancer vs. hepatocellular carcinoma).

Main Methods:

  • HCV genotyping was performed using slot-blot hybridization with type-specific cDNA probes.
  • Restriction fragment length polymorphism (RFLP) analysis was also employed for HCV genotyping.

Related Experiment Videos

  • Patient samples were collected from Japan, Europe, Brazil, USA, and China.

    • Main Results:

    • In Japan, HCV-K1 was the predominant genotype (77.7% in non-cancer, 74.4% in HCC patients), with HCV-PT being rare (0.8%).
    • European and Brazilian populations showed a higher prevalence of HCV-PT (42.1% and similar to Europeans, respectively) and HCV-K1 (52.6%), with no HCV-K2 detected.
    • In the USA, HCV-PT was found in 70% of samples, while in China, HCV-K1 and HCV-K2a were most common (44.4% and 50.0%, respectively), with HCV-PT absent.

    Conclusions:

    • Significant geographical variations exist in the prevalence of hepatitis C virus genotypes.
    • Hepatitis C virus genotype distribution differs between populations in Japan, Europe, Brazil, USA, and China.
    • Further research is needed to understand the implications of these genotype distributions on disease progression and treatment outcomes.